Skip to main content

Table 2 Summary of economic evaluations comparing supervised centre-based cardiac rehabilitation (CR) vs no cardiac rehabilitation (No-CR)

From: A systematic review of economic evaluations of cardiac rehabilitation

Author (Year)

Perspective

Patient populations

Study type

Currency, price year

Findings

Levin et al. (1991)

Societal

N = 305 after MI

CCA

Swedish kroner, ?year

CR: SEK73,500 less per patient

Ades et al. 1992

Patients/ payers

N = 580 after MI/CABG

CCA

US dollars, 1991

CR: $739 less in hospitalization costs per patient

Oldridge et al. (1993)

Societal

N = 201 after MI

CUA/ modelling

US dollars, 1991

CR: $21,800 per life-year gained; $9,200 per QALY gained at 1 year

Ades et al. (1997)

Patients/ Payers

Not applicable

Economic modeling

US dollars, 1995

CR: $4,950 per year of life saved

Georgiou et al. (2001)

Societal

N = 99 with HF

CEA

US dollars, 1999

ICER = $1,773 per life year saved in favour of CR

Marchionni et al. (2003)

Government or care providers

N = 158 with MI

CCA

US dollars, 2000

CR: $21,298 per patient vs $12,433 per patient in No-CR group

Yu et al. (2004)

Government

N = 204 after MI or PCI

CUA

US dollars, ?year

ICUR = $650 per QALY in favour of CR

Huang et al. (2008)

Government

N = 4,324 after CABG

CEA

US dollars, 1998

ICER = 13,887 per year of life saved in favour of CR

Dendale et al. (2008)

Health care payers

N = 213 after PCI

CEA

Euro, ?year

CR: 4,862€ per patient and 5,498€ per patient in No-CR group

  1. MI, myocardial infarction. HF, heart failure. CABG, coronary artery bypass graft surgery. PCI, percutaneous coronary intervention. CCA, cost-consequences analysis. CEA, cost-effectiveness analysis. CUA, cost-utility analysis. QALY, quality-adjusted life-years. ICER, incremental cost-effectiveness ratio. ICUR, incremental cost-utility ratio.